Immunological analysis during ETV-IFN Sequential therapy for CHB patients

Immunological analysis during ETV-IFN Sequential therapy for CHB patients - EISEQB

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007401

Enrollment

Registered

2012-03-01

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHB

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HBV-DNA>7 log copies/ml

Exclusion criteria

Exclusion criteria: Liver disease with other factors

Design outcomes

Primary

Measure	Time frame
Immunological parameter	—

Countries

Japan

Contacts

Public ContactYasuteru Kondo

Tohoku University Hospital Gastroenterology

022-717-7171

Outcome results